These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 14702546)

  • 1. Sirolimus-atorvastatin drug interaction in the pancreatic islet transplant recipient.
    Barshes NR; Goodpastor SE; Goss JA
    Transplantation; 2003 Dec; 76(11):1649-50. PubMed ID: 14702546
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of atorvastatin on cyclosporine pharmacokinetics in liver transplant recipients.
    Taylor PJ; Kubler PA; Lynch SV; Allen J; Butler M; Pillans PI
    Ann Pharmacother; 2004 Feb; 38(2):205-8. PubMed ID: 14742751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin independence after conversion to tacrolimus and sirolimus-based immunosuppression in islet-kidney recipients.
    Toso C; Morel P; Bucher P; Mathe Z; Demuylder-Mischler S; Bosco D; Berney T; Oberholzer J; Shapiro J; Oberholzer J; Philippe J
    Transplantation; 2003 Oct; 76(7):1133-4. PubMed ID: 14557767
    [No Abstract]   [Full Text] [Related]  

  • 4. Formulary conversion programs: the need for patient-specific risk assessment.
    Singh S; Shrivastava R; Das V
    MedGenMed; 2004 Sep; 6(3):28. PubMed ID: 15520652
    [No Abstract]   [Full Text] [Related]  

  • 5. Elevated portal vein drug levels of sirolimus and tacrolimus in islet transplant recipients: local immunosuppression or islet toxicity?
    Desai NM; Goss JA; Deng S; Wolf BA; Markmann E; Palanjian M; Shock AP; Feliciano S; Brunicardi FC; Barker CF; Naji A; Markmann JF
    Transplantation; 2003 Dec; 76(11):1623-5. PubMed ID: 14702535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparative study of atorvastatin and simvastatin as monotherapy for mixed hyperlipidaemia in Type 2 diabetic patients.
    Chan WB; Ko GT; Yeung VT; Osaki R; Ma RC; So WY; Chow CC
    Diabetes Res Clin Pract; 2004 Oct; 66(1):97-9. PubMed ID: 15364167
    [No Abstract]   [Full Text] [Related]  

  • 7. Journal Watch: evidence that Atorvastatin reduces the risk of stroke and myocardial infarction in patients with type 2 diabetes, but with no evidence of dyslipidaemia.
    Gangaidzo IT
    Cent Afr J Med; 2005; 51(11-12):125-6. PubMed ID: 17447346
    [No Abstract]   [Full Text] [Related]  

  • 8. Impact of a sirolimus/tacrolimus-based immunosuppressive regimen on kidney function after islet transplantation.
    Andres A; Toso C; Morel P; Demuylder-Mischler S; Bosco D; Baertschiger R; Pernin N; Bucher P; Majno PE; Bühler LH; Berney T
    Transplant Proc; 2005 Mar; 37(2):1326-7. PubMed ID: 15848711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Statin therapy improves brachial artery vasodilator function in patients with Type 1 diabetes and microalbuminuria.
    Dogra GK; Watts GF; Chan DC; Stanton K
    Diabet Med; 2005 Mar; 22(3):239-42. PubMed ID: 15717868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Statins for high-risk patients without heart disease or high cholesterol.
    Med Lett Drugs Ther; 2006 Jan; 48(1225):1-3. PubMed ID: 16374400
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of atorvastatin therapy and conversion to tacrolimus on hypercholesterolemia and endothelial dysfunction after renal transplantation.
    Wissing KM; Unger P; Ghisdal L; Broeders N; Berkenboom G; Carpentier Y; Abramowicz D
    Transplantation; 2006 Sep; 82(6):771-8. PubMed ID: 17006324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of sirolimus alone with sirolimus plus tacrolimus in type 1 diabetic recipients of cultured islet cell grafts.
    Gillard P; Ling Z; Mathieu C; Crenier L; Lannoo M; Maes B; Roep B; Gorus F; Pipeleers D; Keymeulen B
    Transplantation; 2008 Jan; 85(2):256-63. PubMed ID: 18212631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and efficacy of statin therapy in patients switched from cyclosporine a to sirolimus after cardiac transplantation.
    Aliabadi AZ; Mahr S; Dunkler D; Grömmer M; Zimpfer D; Wolner E; Grimm M; Zuckermann AO
    Transplantation; 2008 Dec; 86(12):1771-6. PubMed ID: 19104420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [To lessen the cardiovascular risk of the diabetic patient. Atorvastatin of use for diabetic patients without coronary disease, too].
    MMW Fortschr Med; 2005 Aug; 147(33-34):51. PubMed ID: 16138641
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of cyclosporin A and itraconazole on the pharmacokinetics of atorvastatin in rats.
    Dong J; Yu X; Wang L; Sun YB; Chen XJ; Wang GJ
    Acta Pharmacol Sin; 2008 Oct; 29(10):1247-52. PubMed ID: 18817631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atorvastatin does not affect the antiplatelet potency of clopidogrel when it is administered concomitantly for 5 weeks in patients with acute coronary syndromes.
    Mitsios JV; Papathanasiou AI; Rodis FI; Elisaf M; Goudevenos JA; Tselepis AD
    Circulation; 2004 Mar; 109(11):1335-8. PubMed ID: 15023882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does statin therapy improve cardiovascular outcomes in patients with type 2 diabetes receiving hemodialysis?
    Kwan BC; Beddhu S; Kronenberg F; Cheung AK
    Nat Clin Pract Nephrol; 2006 Feb; 2(2):76-7. PubMed ID: 16932397
    [No Abstract]   [Full Text] [Related]  

  • 18. No pharmacokinetic or pharmacodynamic interaction between atorvastatin and the oral direct thrombin inhibitor ximelagatran.
    Sarich TC; Schützer KM; Dorani H; Wall U; Kalies I; Ohlsson L; Eriksson UG
    J Clin Pharmacol; 2004 Aug; 44(8):928-34. PubMed ID: 15286097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of atorvastatin on endothelial function and inflammation in long-duration type 1 diabetic patients without coronary heart disease and arterial hypertension.
    Konduracka E; Galicka-Latala D; Cieslik G; Rostoff P; Fedak D; Sieradzki J; Naskalski J; Piwowarska W
    Diabetes Obes Metab; 2008 Sep; 10(9):719-25. PubMed ID: 17941871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of rosiglitazone alone and in combination with atorvastatin on nontraditional markers of cardiovascular disease in patients with type 2 diabetes mellitus.
    Chu CS; Lee KT; Lee MY; Su HM; Voon WC; Sheu SH; Lai WT
    Am J Cardiol; 2006 Mar; 97(5):646-50. PubMed ID: 16490430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.